How Much Does Prometrium Cost in Maryland in 2026?

Maryland Retail Pricing: Brand vs. Generic vs. Compounded

The sticker shock of a $180 monthly list price rarely reflects what a Maryland patient actually pays at the register. That figure represents the wholesale acquisition cost set by AbbVie (formerly Solvay Pharmaceuticals), and it applies only to the brand-name Prometrium capsule before any discounts, insurance adjudication, or pharmacy benefit processing.

Across Maryland retail pharmacies in 2026, the average cash-pay price for a 30-day supply of generic micronized progesterone 200 mg capsules lands near $45. This price varies by chain. Costco and independent pharmacies in Baltimore, Bethesda, and Annapolis often undercut large chains by $5 to $15 per fill. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial established micronized progesterone as the preferred progestogen for endometrial protection during hormone therapy, demonstrating that it preserved HDL cholesterol levels better than medroxyprogesterone acetate over 36 months of follow-up 1. That finding pushed micronized progesterone into widespread clinical use and drove generic manufacturing, which is the main reason Maryland patients can now fill the prescription for a quarter of the brand cost.

A third option exists. Licensed 503A compounding pharmacies operating in Maryland can prepare micronized progesterone capsules for approximately $25 per month. The compound uses the same USP-grade micronized progesterone powder as the manufactured product. Compounded versions are not FDA-approved finished dosage forms, but they are legal when dispensed pursuant to a valid patient-specific prescription under section 503A of the Federal Food, Drug, and Cosmetic Act 2.

Price alone should not determine the choice between generic and compounded product. The FDA-approved generic undergoes bioequivalence testing and carries consistent lot-to-lot potency. Compounded capsules do not undergo the same regulatory scrutiny, a distinction the FDA has addressed in multiple guidance documents.

Maryland Medicaid Coverage for Prometrium

Maryland Medicaid does cover Prometrium and its generic equivalents, but the formulary classification requires prior authorization (PA). That means the prescribing clinician must submit documentation showing the patient meets coverage criteria before the pharmacy can process the claim.

The PA process in Maryland typically requires evidence that the patient has a clinical indication consistent with the FDA-approved labeling: prevention of endometrial hyperplasia in postmenopausal women receiving conjugated estrogens, or treatment of secondary amenorrhea 3. Maryland's Medicaid program, administered by the Maryland Department of Health, aligns its PA criteria with the FDA label. Off-label uses (such as luteal phase support during fertility treatment) may require additional clinical justification.

Turnaround time for PA approval ranges from 24 hours to 5 business days in Maryland. The prescriber's office submits the request electronically through the state's preferred benefits manager. If the initial PA is denied, a peer-to-peer review can be requested. Patients waiting on PA approval can fill a short bridge supply at cash-pay pricing to avoid gaps in therapy. The PEPI trial data 1 is often referenced in PA appeals because it provides Level I evidence for micronized progesterone's role in HRT regimens.

For patients enrolled in a Maryland Medicaid managed care organization (MCO) such as CareFirst Community Health Plan, Priority Partners, or Amerigroup, the specific formulary tier may differ from fee-for-service Medicaid. Each MCO publishes its own preferred drug list. Generic micronized progesterone sits on most MCO formularies at Tier 2 or lower.

Private Insurance and Employer Plans in Maryland

Most commercial insurance plans sold on the Maryland Health Benefit Exchange and most employer-sponsored plans cover generic micronized progesterone. Coverage for the brand-name Prometrium product varies. Plans that use a closed formulary may require step therapy, meaning the patient must try the generic first before the brand product will be approved.

Copay amounts depend on the plan tier. For generic micronized progesterone on a typical Maryland PPO or HMO plan, expect a Tier 1 or Tier 2 copay between $5 and $25 per fill. Brand Prometrium, if covered, usually falls on Tier 3 with a copay between $40 and $75. High-deductible health plans (HDHPs) paired with a health savings account (HSA) require the patient to pay the negotiated rate until the deductible is met. Under an HDHP, the negotiated rate for generic micronized progesterone at Maryland pharmacies typically runs $30 to $50 per fill.

The Affordable Care Act's preventive care mandates do not classify progesterone supplementation as a zero-cost preventive service, so cost-sharing applies in all plan types. Patients on CareFirst BlueCross BlueShield, the dominant Maryland insurer, should verify their specific formulary online or call the member services number on the back of the card before assuming a copay amount.

AbbVie Savings Card and Manufacturer Discounts

AbbVie offers a manufacturer savings card for brand-name Prometrium that reduces out-of-pocket cost for commercially insured patients. The card is accepted at virtually all Maryland retail pharmacies. Eligibility requirements exclude patients enrolled in any federal or state healthcare program, including Medicare Part D, Medicaid, TRICARE, and the VA.

For eligible patients, the savings card can reduce the monthly copay to as low as $0 to $25, depending on the plan's allowed amount. The card typically covers the difference between the patient's copay and a target out-of-pocket amount set by AbbVie. Annual caps apply. Patients should confirm current terms directly on the AbbVie website, as program details change by calendar year.

GoodRx, RxSaver, and similar discount aggregator platforms also provide coupons for generic micronized progesterone in Maryland. These coupons are not insurance. They represent pre-negotiated cash rates between the aggregator and the pharmacy. Using a coupon means the purchase does not count toward the patient's insurance deductible. For patients who have already met their deductible, insurance adjudication almost always produces a lower out-of-pocket cost than a coupon.

Compounded Micronized Progesterone in Maryland: Legal Framework

Compounded micronized progesterone is legal in Maryland when dispensed by a pharmacy operating under a valid 503A license. Section 503A of the Federal Food, Drug, and Cosmetic Act permits a licensed pharmacist to compound a drug product for an individual patient based on a valid prescription from a licensed prescriber 2. Maryland's Board of Pharmacy regulates compounding pharmacies within the state and conducts inspections for compliance with United States Pharmacopeia (USP) chapters 795 and 797.

Patients may prefer compounded micronized progesterone for several reasons: lower cost (approximately $25 per month), the ability to obtain custom dosages not available in the manufactured product (the FDA-approved capsules come in 100 mg and 200 mg strengths only), or the option to receive the hormone in alternative delivery forms such as vaginal suppositories or topical creams.

The Endocrine Society's 2022 clinical practice guideline on menopausal hormone therapy notes that oral micronized progesterone is the preferred progestogen for endometrial protection but does not distinguish between manufactured and compounded formulations in its dosing recommendations 4. The 2022 North American Menopause Society (NAMS) position statement similarly recommends micronized progesterone as the progestogen with the most favorable cardiovascular and breast safety profile based on observational data 5.

One practical limitation: compounded products are not covered by insurance. The $25 per month cost is entirely out of pocket. For patients whose insurance copay exceeds $25 for the manufactured generic, the compounded version may be cheaper even without coverage. For patients with a low generic copay, the manufactured product is both less expensive and subject to tighter quality controls.

Telehealth Prescribing of Prometrium in Maryland

Maryland permits telehealth prescribing of Prometrium and generic micronized progesterone. The Maryland Board of Physicians allows licensed prescribers to evaluate patients via synchronous audio-video telehealth and issue prescriptions for non-controlled substances, which includes progesterone 6. There is no requirement for an in-person visit before a telehealth prescription for this medication class.

Telehealth can reduce the total cost of obtaining Prometrium by eliminating the office visit copay, which runs $25 to $75 at most Maryland practices. Several telehealth platforms operating in Maryland specialize in hormone therapy and can prescribe micronized progesterone, order confirmatory labs, and send the prescription to the patient's preferred local pharmacy.

Patients using telehealth should confirm that the prescribing clinician holds an active Maryland medical license. A prescription written by a provider not licensed in Maryland cannot be filled at a Maryland pharmacy. The prescription itself is transmitted electronically to the pharmacy and processed identically to one generated during an in-person visit.

How to Minimize Your Prometrium Cost in Maryland

A systematic approach to cost reduction starts with identifying your coverage status and then working through the available options in order of likely savings.

Step 1: Check your formulary. If you have insurance, log in to your plan's online portal or call member services to confirm whether generic micronized progesterone is on formulary and what your copay will be. Generic coverage with a Tier 1 or Tier 2 copay is the most common scenario and typically produces a cost between $5 and $25.

Step 2: Ask about the AbbVie savings card. If your plan covers only the brand and the copay is high, the manufacturer savings card may reduce it significantly. This step only applies to commercially insured patients, not Medicare or Medicaid enrollees.

Step 3: Compare pharmacy prices. Maryland pharmacy prices for the same generic drug can vary by $10 to $20 across chains. Use a price comparison tool or call two or three pharmacies near you. Costco pharmacies do not require a membership for prescription purchases in Maryland.

Step 4: Consider compounding. If your out-of-pocket cost for the manufactured generic exceeds $25, a compounded version from a licensed 503A pharmacy may save money. Confirm the pharmacy's licensure status through the Maryland Board of Pharmacy before filling.

Step 5: Apply for patient assistance. Patients who are uninsured and meet income criteria may qualify for AbbVie's patient assistance program, which can provide brand Prometrium at no cost. Eligibility is typically limited to households earning below 200% to 400% of the federal poverty level.

According to the PEPI trial, micronized progesterone 200 mg taken cyclically (12 days per month) provided full endometrial protection when combined with conjugated equine estrogen 0.625 mg daily 1. This cyclic dosing schedule means a 30-day supply can be stretched across a calendar month for patients on a cyclic regimen, since only 12 capsules are consumed rather than 30. That dosing pattern cuts the monthly cost by roughly 60% regardless of the pricing pathway used.

Dr. JoAnn Manson, professor of medicine at Harvard Medical School and principal investigator of the Women's Health Initiative hormone therapy trials, has stated: "Micronized progesterone has a more favorable safety profile than synthetic progestins, and cost should not be a barrier to its use when clinically indicated" 7. The 2017 Endocrine Society scientific statement she co-authored recommends against substituting synthetic progestins solely for cost reasons when micronized progesterone is accessible.

The North American Menopause Society's 2022 hormone therapy position statement reinforces this point: "The choice of progestogen should be guided by clinical evidence, patient preference, and tolerability rather than cost alone" 5.

Dosing, Timing, and Practical Considerations

Prometrium and generic micronized progesterone capsules are taken orally, once daily at bedtime. Bedtime dosing is specified on the FDA label because the drug causes drowsiness, a side effect that becomes therapeutic when aligned with sleep 3. The capsules contain peanut oil as an excipient. Patients with peanut allergy should use a compounded formulation prepared without peanut oil or a different progestogen entirely.

Standard dosing for endometrial protection: 200 mg orally at bedtime for 12 sequential days per 28-day cycle when combined with daily estrogen. Continuous combined regimens use 100 mg nightly. The dose and schedule should be determined by the prescribing clinician based on the specific HRT regimen, menopausal status, and patient history.

For secondary amenorrhea (the other FDA-approved indication), the standard regimen is 400 mg at bedtime for 10 days. Withdrawal bleeding typically occurs within 3 to 7 days of completing the course.

Patients filling their prescription at Maryland pharmacies should verify that they receive the correct strength. Micronized progesterone capsules come in 100 mg and 200 mg strengths, and the two are sometimes confused during dispensing. The 100 mg capsule is typically peach-colored and round; the 200 mg capsule is typically off-white and oval, though appearance varies by manufacturer.